MEDPLUS.NS

MedPlus Health Services Limited [MEDPLUS.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MEDPLUS.NS Stock Summary

Top 10 Correlated ETFs

MEDPLUS.NS


Top 10 Correlated Stocks

MEDPLUS.NS


In the News

MEDPLUS.NS Financial details

Company Rating
Buy
Market Cap
81.99B
Income
586.59M
Revenue
53.87B
Book val./share
129.51
Cash/share
16.64
Dividend
-
Dividend %
-
Employees
19.63K
Optionable
No
Shortable
Yes
Earnings
05 Feb 2024
P/E
151.75
Forward P/E
72.25
PEG
-33.7
P/S
1.72
P/B
5.81
P/C
41.34
P/FCF
400.15
Quick Ratio
0.44
Current Ratio
2.87
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.7
EPS next Y
9.52
EPS next Q
-
EPS this Y
-51.23%
EPS next Y
102.64%
EPS next 5Y
-
EPS last 5Y
33.05%
Revenue last 5Y
15.07%
Revenue Q/Q
2.33%
EPS Q/Q
-5.74%
-
-
-
-
SMA20
-2.71%
SMA50
-8.34%
SMA100
-14.77%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
4%
ROC
0.06%
Gross Margin
22%
Oper. Margin
3%
Profit Margin
1%
Payout
-
Shs Outstand
119.31M
Shs Float
45.96M
-
-
-
-
Target Price
-
52W Range
598.6-978.0
52W High
-29.67%
52W Low
+15.03%
RSI
52
Rel Volume
2.09
Avg Volume
192.12K
Volume
401.86K
Perf Week
1.93%
Perf Month
14.08%
Perf Quarter
-9.68%
Perf Half Y
-9.65%
-
-
-
-
Beta
0.873
-
-
Volatility
2.37%, 15.09%
Prev Close
0.41%
Price
687.85
Change
1.1%

MEDPLUS.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
189.33238.99255.71335.17382.01
Net income per share
10.185.358.554.17
Operating cash flow per share
12.29-0.550.2415.167.58
Free cash flow per share
10.47-3.08-4.314.66-6.59
Cash per share
4.1811.8112.558.6924.82
Book value per share
24.4244.2461.23126.54124.99
Tangible book value per share
20.8540.5457.49122.23120.83
Share holders equity per share
24.4244.2461.23126.54124.99
Interest debt per share
39.9443.8753.9678.6682.39
Market cap
133.76B133.76B133.76B113.67B77.51B
Enterprise value
137.79B137.39B138.59B121.6B84.23B
P/E ratio
1.12K6.14K209.46118.65155.76
Price to sales ratio
5.924.694.383.031.7
POCF ratio
91.19-2.03K4.63K66.9185.73
PFCF ratio
107.07-363.48-260.4217.89-98.62
P/B Ratio
45.9125.3418.318.025.2
PTB ratio
45.9125.3418.318.025.2
EV to sales
6.14.824.543.241.85
Enterprise value over EBITDA
105.4875.359.0740.5326.98
EV to operating cash flow
93.94-2.09K4.79K71.5893.16
EV to free cash flow
110.3-373.35-269.81233.1-107.17
Earnings yield
0000.010.01
Free cash flow yield
0.01000-0.01
Debt to equity
1.470.90.810.570.6
Debt to assets
0.450.350.380.310.32
Net debt to EBITDA
3.091.992.062.642.15
Current ratio
1.261.72.222.923.11
Interest coverage
1.292.12.522.451.16
Income quality
6.45-0.220.031.441.92
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010000
Research and developement to revenue
00000
Intangibles to total assets
0.040.030.030.020.02
Capex to operating cash flow
-0.154.59-18.77-0.69-1.87
Capex to revenue
-0.01-0.01-0.02-0.03-0.04
Capex to depreciation
-0.37-0.4-0.61-0.99-0.93
Stock based compensation to revenue
000.0100
Graham number
23.4313.4985.87156.02108.3
ROIC
0.0300.050.040.03
Return on tangible assets
0.0100.040.040.02
Graham Net
-33.69-29.51-25.68-5.11-36.17
Working capital
971.98M3.35B5.08B10.73B10.04B
Tangible asset value
2.49B4.84B6.86B13.7B14.42B
Net current asset value
-1.98B-38.17M885.22M4.55B1.75B
Invested capital
1.470.90.810.570.6
Average receivables
0155.3M58.84M57.02M73.44M
Average payables
01.96B1.91B1.97B2.53B
Average inventory
05.19B6.97B8.32B10.3B
Days sales outstanding
3.980.820.640.590.69
Days payables outstanding
31.2836.5622.2930.1426.69
Days of inventory on hand
77.95100.48112.88111.98117.38
Receivables turnover
91.6445.51568.43622.16526.83
Payables turnover
11.679.9816.3712.1113.68
Inventory turnover
4.683.633.233.263.11
ROE
0.0400.090.070.03
Capex per share
-1.82-2.53-4.55-10.51-14.17

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
100.1280.63108.55117.99120.77
Net income per share
1.131.710.321.221.15
Operating cash flow per share
7.71.428.869.299.57
Free cash flow per share
7.71.428.869.299.57
Cash per share
96.3419.0671.1819.1116.64
Book value per share
122.8395.96126.72127.55129.51
Tangible book value per share
122.8392.76126.72123.26129.51
Share holders equity per share
122.8395.96126.72127.55129.51
Interest debt per share
1.7959.341.9782.232.05
Market cap
72.95B100.96B91.68B91.78B88.4B
Enterprise value
69.76B107.68B89.18B100.16B86.41B
P/E ratio
136.0394.95605.39157.55161
Price to sales ratio
6.138.067.146.526.13
POCF ratio
79.66456.4587.4682.7377.39
PFCF ratio
79.66456.4587.4682.7377.39
P/B Ratio
56.776.126.035.72
PTB ratio
56.776.126.035.72
EV to sales
5.868.596.947.115.99
Enterprise value over EBITDA
83.97112.96110.46104.9385.07
EV to operating cash flow
76.18486.8185.0790.2875.65
EV to free cash flow
76.18486.8185.0790.2875.65
Earnings yield
00000
Free cash flow yield
0.0100.010.010.01
Debt to equity
00.600.630
Debt to assets
00.3200.330
Net debt to EBITDA
-3.837.05-3.18.78-1.96
Current ratio
3.123.113.092.872.93
Interest coverage
1.771.770.811.71.81
Income quality
6.830.8327.697.628.32
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.03000
Research and developement to revenue
00000
Intangibles to total assets
00.0200.020
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00.02000
Graham number
55.8360.7730.2159.1757.89
ROIC
0.020.020.010.010.02
Return on tangible assets
00.0100.010
Graham Net
35.65-27.777.06-45.5-48.21
Working capital
10.09B10.04B10.12B10.17B10.45B
Tangible asset value
14.6B14.42B14.99B14.71B15.46B
Net current asset value
2.21B1.75B1.46B1.46B1.54B
Invested capital
00.600.630
Average receivables
35.61M43.26M43.26M44.16M44.16M
Average payables
2.84B2.73B2.61B2.81B3B
Average inventory
10.52B11.15B11.65B12.31B12.96B
Days sales outstanding
00.6200.560
Days payables outstanding
27.724.1423.3124.4324.09
Days of inventory on hand
105.58106.15105.6103.92105.59
Receivables turnover
0144.840159.510
Payables turnover
3.253.733.863.683.74
Inventory turnover
0.850.850.850.870.85
ROE
0.010.0200.010.01
Capex per share
00000

MEDPLUS.NS Frequently Asked Questions

What is MedPlus Health Services Limited stock symbol ?

MedPlus Health Services Limited is a IN stock and trading under the symbol MEDPLUS.NS

What is MedPlus Health Services Limited stock quote today ?

MedPlus Health Services Limited stock price is $687.85 today.

Is MedPlus Health Services Limited stock public?

Yes, MedPlus Health Services Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap